GleamWall
中文EN

CPIX CUMBERLAND PHARMACEUTICALS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1087294 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.7%
TTM net income YoY2,167.1%
TTM EPS YoY1,962.5%
Revenue 3-yr CAGR-13.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-38.2%
Net margin273.7%
FCF margin-3.9%
EBITDA margin-33.6%

Returns

ROE139.5%
ROA76.6%
ROIC (approx.)-532.4%
Asset turnover0.28x

Leverage & solvency

Liabilities / assets36.6%
Debt / equity0.00x
Current ratio3.05x
Interest coverage-47.02x

Cash quality & payout

Operating cash flow / net income-0.01x
Accruals ratio77.6%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$44.52M$37.87M
Cost of revenue$6.67M$6.59M
Gross profit$37.85M$31.28M
R&D expense$5.57M$4.82M
SG&A expense$11.95M$11.13M
Operating income-$2.79M-$6.43M
Interest expense$495,990$605,508
Pretax income-$2.81M-$6.47M
Income tax$40,256-$22,669
Net income-$2.84M-$6.48M
EBITDA$1.35M-$1.53M
EPS (basic)-0.19-0.46
EPS (diluted)-0.19-0.46
Weighted avg. shares (diluted)14.85M14.06M
Balance sheet
Cash & equivalents$11.44M$17.96M
Receivables$16.94M$11.70M
Inventory$29,935$4.00M
Current assets$37.06M$36.45M
PP&E, net$264,724$277,365
Goodwill$914,000$914,000
Intangibles$53,621$17.97M
Total assets$76.82M$75.58M
Current liabilities$36.74M$31.62M
Short-term debt$0$5.10M
Total liabilities$52.28M$53.04M
Shareholders' equity$24.88M$22.85M
Shares outstanding14.96M13.95M
Cash flow statement
Operating cash flow$4.93M-$612,186
Capital expenditure$97,903$66,461
Free cash flow$4.83M-$678,647
Investing cash flow-$4.71M$57,842
Financing cash flow-$6.75M$196,904
Depreciation & amortization$4.15M$4.90M
Stock-based compensation$408,320$301,895
Share buybacks$263,478$579,049

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.